Lista de obras -

Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia

artículo científico publicado en 2007

Androgen deprivation modulates gene expression profile along prostate cancer progression.

artículo científico publicado en 2016

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome

artículo científico publicado en 2014

Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas

artículo científico publicado en 2018

Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma

artículo científico publicado en 2015

Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer

Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.

artículo científico publicado en 2011

Functional role and prognostic significance of CD157 in ovarian carcinoma.

artículo científico publicado en 2010

H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.

artículo científico publicado en 2014

High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.

artículo científico publicado en 2018

Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells.

artículo científico

Human ASH1 expression in prostate cancer with neuroendocrine differentiation

artículo científico publicado en 2008

Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma

artículo científico

Images in Endocrine Pathology: Unique Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, Myelolipoma, and Cortical Nodular Hyperplasia

artículo científico publicado en 2017

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome

artículo científico publicado en 2014

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

artículo científico publicado en 2010

Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.

artículo científico publicado en 2010

Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features

scientific article published on 12 June 2019

Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.

artículo científico publicado en 2007

Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth

artículo científico publicado en 2009

Polyol pathway links glucose metabolism to the aggressiveness of cancer cells

artículo científico publicado en 2018

Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues

artículo científico publicado en 2008

RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.

artículo científico publicado en 2009

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer

artículo científico publicado en 2012

Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase

scientific article published on 01 October 2006

Therapeutic biomarkers in lung neuroendocrine neoplasia.

artículo científico

Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors

artículo científico publicado en 2008

Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer

artículo científico publicado en 2017

Lista de obras de

Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia

Androgen deprivation modulates gene expression profile along prostate cancer progression.

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome

Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas

Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma

Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer

Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.

Functional role and prognostic significance of CD157 in ovarian carcinoma.

H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.

High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.

Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells.

Human ASH1 expression in prostate cancer with neuroendocrine differentiation

Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma

Images in Endocrine Pathology: Unique Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, Myelolipoma, and Cortical Nodular Hyperplasia

Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.

Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features

Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.

Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth

Polyol pathway links glucose metabolism to the aggressiveness of cancer cells

Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues

RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact.

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer

Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase

Therapeutic biomarkers in lung neuroendocrine neoplasia.

Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors

Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer